Phase 2 original evidence

Database & Scoring Methodology

The scoring system is designed to reward auditable product information, not loud marketing. A remarkably radical concept for the supplement industry.

Supplement database methodology and research

Data collection rules

  1. Prefer official manufacturer product pages and current official collections.
  2. Record only fields supported by the reviewed source.
  3. Use “Not captured” instead of inferring a missing dose, price, COA or certification.
  4. Snapshot the date because formulas, availability and prices change.
  5. Separate manufacturer claims from independent clinical evidence.
  6. Do not treat a higher milligram number as a higher-quality product.

Transparency Score: 0–10

Points are awarded for explicit active dose, third-party testing, visible COA, GMP disclosure, serving clarity, captured current price and clear ingredient source/form. It measures auditability, not biological effectiveness.

Evidence Match Score: 0–10

This estimates how cleanly the commercial product maps to the ingredient being discussed in human research. Single-active products with disclosed dose and form generally score more cleanly than proprietary or multi-active stacks. It does not predict health outcomes.

Stack Complexity Score: 1–5

1 means a focused single-active product. Higher values indicate more active ingredients or bundled components. Complexity is not automatically good or bad; it simply increases the burden of proof.

Health disclaimer: These scores are editorial research tools, not medical recommendations and not a substitute for individualized professional advice.